Clinical Trial Update: A Study of AMG 557 in Adults With Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

AMG 557 was evaluated in adults with systemic lupus erythematosus in a Phase 1 trial sponsored by Amgen; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• AMG 557

Snippet

Sponsor: Amgen | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: COMPLETED